{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective from the specified list.", "method": "llm_batch", "batch_id": "batch_1_16280", "batch_size": 260, "batch_pos": 140, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 2, "answer": "no", "rationale": "The verbs 'began' and 'was modified' are neutral.", "method": "llm_batch", "batch_id": "batch_2_15720", "batch_size": 260, "batch_pos": 117, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 3, "answer": "no", "rationale": "The segment uses plain verbs like 'began' and 'was modified' without impact scale.", "method": "llm_batch", "batch_id": "batch_3_6056", "batch_size": 260, "batch_pos": 60, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 4, "answer": "no", "rationale": "No loaded rhetorical question is present in the segment.", "method": "llm_batch", "batch_id": "batch_4_9220", "batch_size": 260, "batch_pos": 47, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 5, "answer": "no", "rationale": "This segment reports factual information without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_17372", "batch_size": 260, "batch_pos": 46, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_15604", "batch_size": 260, "batch_pos": 23, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation or an explicit calming cue.", "method": "llm_batch", "batch_id": "batch_7_17208", "batch_size": 260, "batch_pos": 12, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 8, "answer": "no", "rationale": "Segment describes historical development, not capability or preparedness.", "method": "llm_batch", "batch_id": "batch_8_7044", "batch_size": 260, "batch_pos": 137, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 9, "answer": "no", "rationale": "The segment discusses vaccine research beginning with pandemic flu, not prices or numerical metrics.", "method": "llm_batch", "batch_id": "batch_9_17020", "batch_size": 260, "batch_pos": 143, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 10, "answer": "no", "rationale": "The segment states factual research history, not speculation about future relief or improvement.", "method": "llm_batch", "batch_id": "batch_10_18184", "batch_size": 260, "batch_pos": 220, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 11, "answer": "no", "rationale": "Attributed statement provides factual statement without framing.", "method": "llm_batch", "batch_id": "batch_11_8812", "batch_size": 260, "batch_pos": 214, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 12, "answer": "yes", "rationale": "No explicit framing cues; factual report about research history is neutral.", "method": "llm_batch", "batch_id": "batch_12_14728", "batch_size": 260, "batch_pos": 206, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
